4Lee CH, Tai BC, Low AF, et al. Angiographic no-reflow and six-month mortal- ity in elderly ( t> 75 years old) Asian patients undergoing primary percutaneous coronary intervention: a single center experience from 1998 to 2007[J]. Acute Card Care,2010,12(2) :63-69.
5Taylor MR, Carniel E, Mestroni L. Cardiomyopathy, familial dilated [ J ]. 0r- phanet J Rare Dis, 2006,1:27.
6Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated car-diomyopathy[J]. J Am Coll Cardiol, 2005,45(7) :969-981.
7Yoshikawa T, Baba A, Nagatomo Y. Autoimmune mechanisms underlying dilat- ed cardiomyopathy [ J ]. Circ J, 2009,73 (4) :602-607.
8Groenewegen WA, Wilde AA. Letter regarding article by McNair et al, " SCN5A mutation associated with dilated cardiomyopathy, conduction disor- der, and arrhythmia" [ J ]. Circulation, 2005,112 ( 1 ) : e9-10.
9Ge J, Sun A, Paajanen V, et al. Molecular and clinical characterization of novel SCN5A mutation associated with atrioventricular block and dilated cardio. myopathy [ J ]. J Circ Arrhythm Electrophysiol, 2008,1 (2) : 83 -92.
10Hesse M, Kondo CS, Clark RB, et al. Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel ScnSa[ J]. J Cardiovasc Res, 2007,75 ( 3 ) :498-509.
